Anal CancerSymptoms, Doctors, Treatments, Advances & More
Learn About Anal Cancer
Anal cancer is cancer that starts in the anus. The anus is the opening at the end of your rectum. The rectum is the last part of your large intestine where solid waste from food (stool) is stored. Stool leaves your body through the anus when you have a bowel movement.
Anal cancer is an uncommon type of cancer.
Cancer - anus; Squamous cell carcinoma - anal; HPV - anal cancer
Anal cancer can start anywhere in the anus. Where it starts determines the kind of cancer it is.
- Squamous cell carcinoma. This is the most common type of anal cancer. It starts in cells that line the anal canal and grows into the deeper tissue.
- Cloacogenic carcinoma. Almost all the rest of anal cancers are tumors that start in cells lining the area between the anus and rectum. Cloacogenic carcinoma looks different than squamous cell cancers under a microscope, but behaves similarly and is treated the same.
- Adenocarcinoma. This type of anal cancer is rare in the United States. It starts in the anal glands below the anal surface and is often more advanced when it is found.
- Skin cancer. Some cancers form outside the anus in the perianal area. This area is mainly skin. The tumors here are skin cancers and are treated as skin cancer.
The cause of anal cancer is unclear. However, there is a link between anal cancer and the human papillomavirus or HPV infection. HPV is a sexually transmitted virus that has been linked to other cancers as well.
Other major risk factors include:
- HIV/AIDS infection. Anal cancer is more common among HIV/AIDS positive men who have sex with other men.
- Sexual activity. Having many sexual partners and having anal sex are both major risks. This may be due to the increased risk for HPV and HIV/AIDS infection.
- Smoking.Quitting will reduce your risk for anal cancer.
- Weak immune system. HIV/AIDS, organ transplants, certain medicines, and other conditions that weaken the immune system increase your risk.
- Age. Most people who have anal cancer are age 50 or older. In rare cases, it is seen in people younger than age 35.
- Sex and race. Anal cancer is more common among women than men in most groups. More African American males get anal cancer than African American females.
Rectal bleeding, often minor, is one of the first signs of anal cancer. Often, a person mistakenly thinks the bleeding is caused by hemorrhoids.
Other early signs and symptoms include:
- A lump in or near the anus
- Anal pain
- Itching
- Discharge from the anus
- Change in bowel habits
- Swollen lymph nodes in the groin or anal region
Treatment for anal cancer is based on:
- The stage of the cancer
- Where the tumor is located
- Whether the cancer has resisted initial treatment or has come back after initial treatment
In most cases, anal cancer that hasn't spread can be treated with radiation therapy and chemotherapy together. The combination of radiation and chemotherapy achieves better tumor control than the use of radiation alone.
For very small tumors, surgery alone is typically used, instead of radiation and chemotherapy.
If cancer remains after the radiation and chemotherapy, surgery is often required. This may involve removing the anus, the rectum, and part of the colon. The new end of the large intestine will then be attached to an opening (stoma) in the abdomen. This procedure is called a colostomy. Stools moving through the intestine drain through the stoma into a bag attached to the abdomen.
Beth Israel Deaconess Medical Center-Needham
Theodore Hong is a Radiologist practicing medicine in Needham, Massachusetts. Dr. Hong is rated as an Elite provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Hong is board certified in American Board Of Radiology.
Montefiore Medical Center
Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Elite provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.
Virginia Mason Medical Center
David Aboulafia, MD, has special interest in AIDS/HIV, viral syndromes, general hematology including coagulation and hemostasis, lympho and myeloproliferative disorder, leukemia, lymphoma, myeloma, primary and subspecialty, and HIV-associated malignancies, benign hematology including disorders of coagulation and thrombosis, HIV primary and subspecialty care AIDS defining (Kaposi's sarcoma, lymphoma) and HIV-associated cancer. Dr. Aboulafia is rated as an Elite provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Anal Cancer, Kaposi Sarcoma, B-Cell Lymphoma, and Splenectomy. Dr. Aboulafia is board certified in American Board Of Internal Medicine, Subspecialty In Medical Oncology, Subspecialty In Hematology, Subspecialty In HIV Clinical Care. Dr. Aboulafia is currently accepting new patients.
Cancer affects how you feel about yourself and your life. You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you feel less alone.
You can ask your provider or the staff at the cancer treatment center to refer you to a cancer support group.
With early treatment before anal cancer has spread, there is a high cure rate with treatment.
You may have side effects from surgery, chemotherapy, or radiation therapy.
See your provider if you notice any of the possible symptoms of anal cancer, especially if you have any of the risk factors for it.
Since the cause of anal cancer is unknown, it's not possible to completely prevent it. But you can take steps to lower your risk.
- Practice safer sex to help prevent HPV and HIV/AIDS infections. People who have sex with many partners or have unprotected anal sex are at high risk of developing these infections. Using condoms can offer some protection, but not total protection. Talk with your provider about your options.
- Ask your provider about the HPV vaccine and if you should get it.
- Do not smoke. If you do smoke, quitting can lower your risk for anal cancer as well as other diseases.
All adults with HIV should have the following screening test for anal cancer:
- Digital anorectal examination (DARE) and assessment for symptoms of for anal cancer at least once per year
- People under the age of 35 who have symptoms or signs of anal cancer during DARE should undergo standard anoscopy.
Adults with HIV should have other tests along with high resolution anoscopy (HRA), rather than standard anoscopy, if they are:
- Men who have sex with men who are age 35 and older
- Transgender women who are age 35 and older
- All other people with HIV ages 45 and older
If HRA is not available, people with HIV should continue to be screened using an assessment of symptoms and DARE. People with any symptoms or signs of anal cancer should have standard anoscopy, without the collection of anal specimens for diagnosis.
Summary: The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention (self-sampling of the anal canal) and if it affects cytology and high-resolution anoscopy (HRA) appointment attendance. Secondarily, the study will assess if a person who gets their choice of either s...
Summary: The ANTARES study is a phase II basket trial designed to evaluate the tissue-agnostic efficacy of the monoclonal anti-PD1 antibody, nivolumab, in patients with advanced or metastatic rare tumors. The study aims to treat rare malignancies with PD-L1 expression (CPS ≥ 10), regardless of the tumor's tissue type or location. Patients who have not responded to standard treatments will be included, and ...
Published Date: August 21, 2024
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
ClinicalinfoHIV.gov website. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/human?view=full. Updated July 9, 2024. Reviewed January 8, 2025. Accessed May 30, 2025.
Goodman K, Kachnic LA, Czito BG. Cancer of the anal canal. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 76.
Madoff RD, Melton GB. Diseases of the rectum and anus. In: Goldman L, Cooney K, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 131.
National Cancer Institute website. Anal cancer treatment (PDQ) - health professional version. www.cancer.gov/types/anal/hp/anal-treatment-pdq. Updated February 12, 2025. Accessed May 30, 2025.